BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 38161105)

  • 1. Association between sociodemographic factors and diagnosis of lethal prostate cancer in early life.
    Smani S; Novosel M; Sutherland R; Jeong F; Jalfon M; Marks V; Rajwa P; Nolazco JI; Washington SL; Renzulli JF; Sprenkle P; Kim IY; Leapman MS
    Urol Oncol; 2024 Feb; 42(2):28.e9-28.e20. PubMed ID: 38161105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of insurance status and ethnicity with cancer stage at diagnosis for 12 cancer sites: a retrospective analysis.
    Halpern MT; Ward EM; Pavluck AL; Schrag NM; Bian J; Chen AY
    Lancet Oncol; 2008 Mar; 9(3):222-31. PubMed ID: 18282806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostate cancer outcomes for men aged younger than 65 years with Medicaid versus private insurance.
    Mahal AR; Mahal BA; Nguyen PL; Yu JB
    Cancer; 2018 Feb; 124(4):752-759. PubMed ID: 29084350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of insurance and race/ethnicity with disease severity among men diagnosed with prostate cancer, National Cancer Database 2004-2006.
    Fedewa SA; Etzioni R; Flanders WD; Jemal A; Ward EM
    Cancer Epidemiol Biomarkers Prev; 2010 Oct; 19(10):2437-44. PubMed ID: 20705937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Impact of Insurance Status on Tumor Characteristics and Treatment Selection in Contemporary Patients With Prostate Cancer.
    Fossati N; Nguyen DP; Trinh QD; Sammon J; Sood A; Larcher A; Guazzoni G; Montorsi F; Briganti A; Menon M; Abdollah F
    J Natl Compr Canc Netw; 2015 Nov; 13(11):1351-8. PubMed ID: 26553765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insurance status as a modifier of the association between race and stage of prostate cancer diagnosis in Florida during 1995 and 2013.
    Ramirez E; Morano J; Beguiristain T; Castro G; de la Vega PR; Nieder AM; Barengo NC
    Cancer Epidemiol; 2019 Apr; 59():104-108. PubMed ID: 30731402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of underinsurance on bladder cancer diagnosis, survival, and care delivery for individuals under the age of 65 years.
    Fletcher SA; Cole AP; Lu C; Marchese M; Krimphove MJ; Friedlander DF; Mossanen M; Kilbridge KL; Kibel AS; Trinh QD
    Cancer; 2020 Feb; 126(3):496-505. PubMed ID: 31626340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Access denied: The relationship between patient insurance status and access to high-volume hospitals.
    Nabi J; Tully KH; Cole AP; Marchese M; Cone EB; Melnitchouk N; Kibel AS; Trinh QD
    Cancer; 2021 Feb; 127(4):577-585. PubMed ID: 33084023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Has the Affordable Care Act Been Associated with Increased Insurance Coverage and Early-stage Diagnoses of Bone and Soft-tissue Sarcomas in Adults?
    Malik AT; Alexander J; Khan SN; Scharschmidt TJ
    Clin Orthop Relat Res; 2021 Mar; 479(3):493-502. PubMed ID: 32805094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of Race, Insurance, and Rurality on Equity of Breast Cancer Care.
    Markey C; Weiss JE; Loehrer AP
    J Surg Res; 2022 Mar; 271():117-124. PubMed ID: 34894544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast cancer stage variation and survival in association with insurance status and sociodemographic factors in US women 18 to 64 years old.
    Hsu CD; Wang X; Habif DV; Ma CX; Johnson KJ
    Cancer; 2017 Aug; 123(16):3125-3131. PubMed ID: 28440864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Insurance Status and Diagnosis Stage Among Patients With Newly Diagnosed Cancer Before vs After Implementation of the Patient Protection and Affordable Care Act.
    Han X; Yabroff KR; Ward E; Brawley OW; Jemal A
    JAMA Oncol; 2018 Dec; 4(12):1713-1720. PubMed ID: 30422152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in prostate-specific antigen at the time of prostate cancer diagnosis after Medicaid expansion in young men.
    Weiner AB; Vo AX; Desai AS; Hu JC; Spratt DE; Schaeffer EM
    Cancer; 2020 Jul; 126(14):3229-3236. PubMed ID: 32343403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relation between health insurance coverage and clinical outcomes among women with breast cancer.
    Ayanian JZ; Kohler BA; Abe T; Epstein AM
    N Engl J Med; 1993 Jul; 329(5):326-31. PubMed ID: 8321261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations of Medicaid Expansion With Insurance Coverage, Stage at Diagnosis, and Treatment Among Patients With Genitourinary Malignant Neoplasms.
    Michel KF; Spaulding A; Jemal A; Yabroff KR; Lee DJ; Han X
    JAMA Netw Open; 2021 May; 4(5):e217051. PubMed ID: 34009349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of health insurance status on stage at diagnosis of oropharyngeal cancer.
    Chen AY; Schrag NM; Halpern MT; Ward EM
    Cancer; 2007 Jul; 110(2):395-402. PubMed ID: 17562558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Sociodemographic and Health-Related Factors With Receipt of Nondefinitive Therapy Among Younger Men With High-Risk Prostate Cancer.
    Bagley AF; Anscher MS; Choi S; Frank SJ; Hoffman KE; Kuban DA; McGuire SE; Nguyen QN; Chapin B; Aparicio A; Pezzi TA; Smith GL; Smith BD; Hess K; Tang C
    JAMA Netw Open; 2020 Mar; 3(3):e201255. PubMed ID: 32191331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insurance status is related to diffuse large B-cell lymphoma survival.
    Han X; Jemal A; Flowers CR; Sineshaw H; Nastoupil LJ; Ward E
    Cancer; 2014 Apr; 120(8):1220-7. PubMed ID: 24474436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insurance status and disparities in disease presentation, treatment, and outcomes for men with germ cell tumors.
    Markt SC; Lago-Hernandez CA; Miller RE; Mahal BA; Bernard B; Albiges L; Frazier LA; Beard CJ; Wright AA; Sweeney CJ
    Cancer; 2016 Oct; 122(20):3127-3135. PubMed ID: 27500561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of payer status on survival in parotid malignancy.
    Stubbs VC; Rajasekaran K; Chen J; Cannady SB; Brant JA; Newman JG
    Am J Otolaryngol; 2019; 40(4):555-559. PubMed ID: 31097206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.